¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2019 ´ëÇÑÁø´ÜÀ¯ÀüÇÐȸ Çмú´ëȸ : 2019-05-29

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2019 ´ëÇÑÁø´ÜÀ¯ÀüÇÐȸ Çмú´ëȸ : 2019-05-29
±³À°ÀÏÀÚ : 2019-05-29
±³À°Àå¼Ò : ´õÄÉÀÌÈ£ÅÚ¼­¿ï ÄÁº¥¼Ç¼¾ÅÍ  
±³À°ÁÖÁ¦ : 2019 ´ëÇÑÁø´ÜÀ¯ÀüÇÐȸ Çмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : À¯ÀüºÐÀÚÁø´ÜÇÐȸ  
´ã´çÀÚ : À̼Ҷó
¿¬¶ôó : 02-795-9914  
À̸ÞÀÏ : kscp1@kams.or.kr      
±³À°Á¾·ù : Áø´Ü°Ë»çÀÇÇаú      
Âü¼®¿¹»óÀοø : 400¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 17 ½Ã°£ 20ºÐ  
¼¼ºÎ¼ö°­·á : 150,000¿ø      
ºñ°í Á¤È¸¿ø-8¸¸¿ø, Àü°øÀÇ-8¸¸¿ø, Àü¹®ÀÇ-12¸¸¿ø,»ê¾÷°è 15¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05-29 Å©¸®½ºÅ»º¼·ë 08:30~09:00 2019 À¯ÀüÀÚ°Ë»ç±â°ü ÁúÆò°¡ ü°è ¹× ½É»ç ÀϹݻçÇ×  ÀÌ¿µ°æ(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 05-29 Å©¸®½ºÅ»º¼·ë 09:00~09:30 Àü»ê ½Ã½ºÅÛÀ» ÀÌ¿ëÇÑ ÇöÀå ½Ç»ç  À¯Á¾ÇÏ(±¹¹Î°Ç°­º¸Çè Àϻ꺴¿ø) 
±³À°½Ã°£ 05-29 Å©¸®½ºÅ»º¼·ë 09:30~09:50 ½É»çÁ¡°ËÇ¥ ¼³¸í – °Ë»ç½Ç ¿î¿µ  ¾ÈÁ¤¿­(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 05-29 Å©¸®½ºÅ»º¼·ë 09:50~10:10 ½É»çÁ¡°ËÇ¥ ¼³¸í – ºÐÀÚÀ¯Àü  ÀåÀÚÇö(³ì½ÊÀÚÀÇ·áÀç´Ü) 
±³À°½Ã°£ 05-29 Å©¸®½ºÅ»º¼·ë 10:10~10:30 ½É»çÁ¡°ËÇ¥ ¼³¸í – ¼¼Æ÷À¯Àü  ÀÌÁø°æ(Çѱ¹¿øÀÚ·ÂÀÇÇпø) 
±³À°½Ã°£ 05-29 ±×·£µåº¼·ëB 09:00~09:30 Screening risk individuals in health check up  È²±Ý·Ï(¼­¿ïÀÇ°úÇבּ¸¼Ò) 
±³À°½Ã°£ 05-29 ±×·£µåº¼·ëB 09:30~10:00 Personal identification and chimerism assay by NGS  ±èÁöÀº(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 05-29 ±×·£µåº¼·ëB 10:00~10:30 NGS-based HLA typing  ¹ÚÀ±Èñ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 05-29 ±Ý°­È¦A 09:00~09:30 Culture & slide preparation  ¼ÕÁ¤¿Á(¼­¿ï¼º¸ðº´¿ø) 
±³À°½Ã°£ 05-29 ±Ý°­È¦A 09:30~10:00 Reading & interpretation  ¼³Ã¢¾È(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 05-29 ±Ý°­È¦A 10:00~10:30 Point issues in past proficiency test  ±è°æÈñ(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 05-29 ±×·£µåº¼·ëB 11:00~12:00 Molecular drivers of inherited hematopoietic malignancies  Mark D. Ewalt(University of Colorado School of Medicine) 
±³À°½Ã°£ 05-29 ±×·£µåº¼·ëB 12:00~13:10 Effectively manage your transplant patients with standardized & clinically validated results   ÁöÇö¼÷(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 05-29 Å©¸®½ºÅ»º¼·ë 12:00~12:30 Clinical genetic testing using NGS: Lessons learned and future direction  Ã¤Á¾Èñ(¼­¿ïÀÇ´ë Èñ±ÍÁúȯ¼¾ÅÍ) 
±³À°½Ã°£ 05-29 Å©¸®½ºÅ»º¼·ë 12:30~13:10 High throughput data analysis using dragen system  Tan, Yue Ying(Sr Bioinformatics Specialist, Illumina) 
±³À°½Ã°£ 05-29 ±×·£µåº¼·ëB 13:10~13:40 Low level somatic mosaicism in neurologic disorders  °­ÈÆö(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 05-29 ±×·£µåº¼·ëB 13:40~14:10 The scope of hereditary tumor syndrome is expanding in the NGS era  ÀÌ¿ìâ(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 05-29 ±×·£µåº¼·ëB 14:10~14:40 Precision genomics and treatment in neuromuscular disorders  ÀÌÁ¤È¯(ÀÌÈ­ÀÇ´ë) 
±³À°½Ã°£ 05-29 ±Ý°­È¦A 13:10~13:40 ±¹³» À¯Àü»ó´ãŬ¸®´Ð ÇöȲ  À¯Á¾ÇÏ(±¹¹Î°Ç°­º¸Çè Àϻ꺴¿ø) 
±³À°½Ã°£ 05-29 ±Ý°­È¦A 13:40~14:10 À¯Àü »ó´ã Ŭ¸®´Ð ½ÃÀÛÇϱ⠠±èµµÈÆ(°è¸íÀÇ´ë) 
±³À°½Ã°£ 05-29 ±Ý°­È¦A 14:10~14:40 À¯Àü »ó´ã Ŭ¸®´Ð ¿î¿µ A, B, C  ½Å°æÈ­(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 05-29 Å©¸®½ºÅ»º¼·ë 13:10~13:40 Data analysis of DNA-Seq  ±è¼±¿µ(Ãæ³²ÀÇ´ë) 
±³À°½Ã°£ 05-29 Å©¸®½ºÅ»º¼·ë 13:40~14:10 Data analysis of RNA-Seq  ÀÌÁØÇü(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 05-29 Å©¸®½ºÅ»º¼·ë 14:10~14:40 Deep learning for genomics  ¼º¹®¿ì(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 05-29 ±×·£µåº¼·ëB 15:10~15:40 Epilepsy-related disorders  ÀÓº´Âù(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 05-29 ±×·£µåº¼·ëB 15:40~16:10 NGS-guided precision medicine in inherited eye disorders  ÇÑÁø¿ì(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 05-29 ±×·£µåº¼·ëB 16:10~16:40 Immune deficiency  ±è¿¹Áø(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 05-29 ±Ý°­È¦A 15:10~15:40 Urea cycle disorders and hyperammonemia  ÀÌ°æÈÆ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 05-29 ±Ý°­È¦A 15:40~16:10 Disorders of carnitine cycle and fatty acid oxidation disorders  ±è¼¼¸²(³ì½ÊÀÚÀÇ·áÀç´Ü) 
±³À°½Ã°£ 05-29 ±Ý°­È¦A 16:10~16:40 Galactosemia  ¾È¼±Çö(¼­¿ïÀÇ°úÇבּ¸¼Ò) 
±³À°½Ã°£ 05-29 Å©¸®½ºÅ»º¼·ë 15:10~15:40 À¯ÀüÀÚÀç¹è¿­ÀÇ Á¤¼ºÀû °ËÃâ  ¼­ÀÚ¿µ(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 05-29 Å©¸®½ºÅ»º¼·ë 15:40~16:10 À¯ÀüÀÚÀç¹è¿­ÀÇ Á¤·®Àû °ËÃâ  Á¶¿µ¿í(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 05-29 Å©¸®½ºÅ»º¼·ë 16:10~16:40 ¿°±â¼­¿­ºÐ¼®À» ÀÌ¿ëÇÑ µ¹¿¬º¯ÀÌ °ËÃâ  ±è¹Ì¿µ(ÇѸ²ÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2019 ´ëÇÑÁø´ÜÀ¯ÀüÇÐȸ Çмú´ëȸ : 2019-05-29""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ¼øõÇâ´ëÇб³Ãµ¾Èº´¿ø ½Å»ý¾Æ¼Ò»ý¼ú : 2019-05-29
´ÙÀ½±Û Ãæ³²´ëÇб³º´¿ø Multidiciplinary approach to Developmental Epileptic Encephalopathy : 2019-05-29
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
345 ÀüºÏ ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ ÀÎÁöÁßÀçÄ¡·áÀÇ ½ÇÁ¦¿Í Àü¸Á : 2018-09-04 0 538 2018-08-08
344 ºÎ»ê ºÎ¿ï°æ³»ºÐºñ´ë»çÇÐȸ 9¿ù Á¤±âÁý´ãȸ : 2018-09-04 0 482 2018-08-08
343 ¼­¿ï Á¦42ȸ ÇѸ²´ëÇб³°­³²¼º½Éº´¿ø ¾È°ú Áý´ãȸ : 2018-09-03 0 858 2018-08-08
342 ¼­¿ï ¼øõÇâ´ëÇм­¿ïº´¿ø Á¦42ȸ º¹ºÎÃÊÀ½ÆÄ ¹× ³»½Ã°æÃÊÀ½ÆÄ Áø´Ü ¿öÅ©¼ó : 2018-09-02 0 934 2018-08-08
341 ºÎ»ê Á¦21ȸ ´ëÇѳ»°úÇÐȸ ºÎ»ê°æ³²Áöȸ ¿¬¼ö°­Á : 2018-09-02 0 851 2018-08-08
340 ¼­¿ï 2018 ¼Ò¾Æ³»ºÐºñÇÐȸ ¿¬¼ö°­Á : 2018-09-02 0 1,186 2018-08-08
339 ´ëÀü ´ëÇѳëÀÎÁ¤½ÅÀÇÇÐȸ Á¦10ȸ Ä¡¸ÅÁø·áÀÇ»ç Àü¹®È­±³À° (part4, 2ÀÏÂ÷) : 2018-09-02 0 590 2018-08-08
338 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø Á¦23ȸ ´ç´¢º´ÀÇ ¿À´Ã°ú ³»ÀÏ : 2018-09-02 0 1,401 2018-08-08
337 ¼­¿ï ´ëÇÑû°¢ÇÐȸ 2018 Á¦19Â÷ º¸Ã»±â¿öÅ©¼¥ : 2018-09-02 0 725 2018-08-08
336 ºÎ»ê 2018³â ´ëÇѹ̼¼¼ö¼úÇÐȸ Ãß°è Microsurgery Workshop : 2018-09-02 0 1,041 2018-08-08
335 ´ëÀü ´ëÇÑÀÓ»ó½Å°æ»ý¸®ÇÐȸ Á¦4ȸ ã¾Æ°¡´Â ¿öÅ©¼ó : 2018-09-02 0 1,005 2018-08-08
334 ´ë±¸ ´ë±¸±¤¿ª½ÃÀÇ»çȸ 2018 Á¾ÇÕÇмú´ëȸ : 2018-09-02 0 719 2018-08-08
333 ¼­¿ï 2018³â ´ëÇÑ¿Ü°úÀÇ»çȸ Ã߰迬¼ö°­Á : 2018-09-02 1 3,005 2018-08-08
332 ´ëÀü ´ëÇѳëÀÎÁ¤½ÅÀÇÇÐȸ Á¦10ȸ Ä¡¸ÅÁø·áÀÇ»ç Àü¹®È­±³À° (part4,1ÀÏÂ÷) : 2018-09-01 0 426 2018-08-08
331 ´ëÀü ´ëÇѳëÀÎÁ¤½ÅÀÇÇÐȸ Á¦10ȸ Ä¡¸ÅÁø·áÀÇ»ç Àü¹®È­±³À° (part4,1ÀÏÂ÷) : 2018-09-01 0 992 2018-08-08
1371 | 1372 | 1373 | 1374 | 1375 | 1376 | 1377 | 1378 | 1379 | 1380
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷